Wordt geladen...
Quantifying the Benefits of Genome-Driven Oncology
The excitement surrounding genomically selected cancer therapy has led many to question whether this treatment paradigm is living up to its initial promise. The MOSCATO study suggests that a genome-driven strategy for cancer therapy improves outcomes in a significant minority of patients who undergo...
Bewaard in:
| Gepubliceerd in: | Cancer Discov |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5500977/ https://ncbi.nlm.nih.gov/pubmed/28576841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-17-0380 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|